U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06981234) titled 'Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial' on May 12.
Brief Summary: The goal of this study is to learn about the effect of the study drug acetazolamide in individuals with Type 1 Diabetes. Specifically, whether acetazolamide provides benefits to the kidneys while minimizing any side effects of the drug. These changes will be measured by laboratory tests that tell us how well the kidneys are functioning.
Study Start Date: Aug. 14, 2024
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes
Intervention:
DRUG: Acetazolamide
Acetazolamide is a potent carbonic anhydrase inhibitor that acts on the renal proxim...